Bambusa Therapeutics, Inc. (BBTX) · INSIDERData sourcesSEC Form 417m ago
House PTR16m ago
SEC 13F16m ago
Robinhood Chain16m ago
Public companyBambusa Therapeutics, Inc.
BBTXCIK 0002044950
Price$15.73
1 year+4.9%
Disclosed transactions20
Buys / sells2 / 0
Max Insider Score43
Connections with evidence7
BBTX · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 43 | JWJeggle Helmut WolfgangDirector, 10% Owner | BBTXBambusa Therapeutics, Inc. Open-market purchase | BUY | $6.00M 375.0K sh | Nov 2, 2026 |
| Nov 2, 2026 traded Nov 2, 2026 |
| 9 | SGSalvia Investment GmbH10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 160.9K sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | XSXu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 94.0K sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | XSXu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 15.8K sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | XSXu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 16.4K sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | XSXu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 10.4K sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | XSXu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 1,753 sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | JWJeggle Helmut WolfgangDirector, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 160.9K sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | XSXu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 37.4K sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | SGSalvia Investment GmbH10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 3.14M sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | XSXu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 147.2K sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | XSXu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Grant or award | A | — 379.1K sh | Oct 29, 2026 | Nov 2, 2026 traded Oct 29, 2026 | +4d | SEC Form 4 | |
| 9 | XSXu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Grant or award | A | — 758.2K sh | Oct 29, 2026 | Nov 2, 2026 traded Oct 29, 2026 | +4d | SEC Form 4 | |
| 21 | JWJeggle Helmut WolfgangDirector, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 4.77M sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 21 | SGSalvia Investment GmbH10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 4.77M sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | SGSalvia Investment GmbH10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 1.47M sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | XSXu ShanshanDirector, See remarks, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 4,155 sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 43 | SGSalvia Investment GmbH10% Owner | BBTXBambusa Therapeutics, Inc. Open-market purchase | BUY | $6.00M 375.0K sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | JWJeggle Helmut WolfgangDirector, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 3.14M sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
| 9 | JWJeggle Helmut WolfgangDirector, 10% Owner | BBTXBambusa Therapeutics, Inc. Derivative conversion | C | — 1.47M sh | Nov 2, 2026 | Nov 2, 2026 traded Nov 2, 2026 | +0d | SEC Form 4 | |
Director, 10% Owner · Nov 2, 2026
Xu ShanshanDirector, See remarks, 10% Owner · Nov 2, 2026 Planned sales and 5% stakes
Form 144, 13D and 13G